secwatch / observer
8-K filed April 10, 2023, 7:59 PM ET CIK 0001749704
debt confidence high sentiment neutral materiality 0.55

AGILITI, INC. \DE: debt financing — Agiliti increases revolver to $300M, extends maturity to 2028

AGILITI, INC. \DE

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

AGILITI, INC. \DE amended revolving credit of $300,000,000 revolving credit facility with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent at Adjusted EURIBOR, Daily Simple RFR or Term SOFR plus 2.75% maturing April 6, 2028.

Instrument
revolving credit
Principal
$300,000,000 revolving credit facility
Counterparty
JPMorgan Chase Bank, N.A., as administrative agent and collateral agent
Rate
Adjusted EURIBOR, Daily Simple RFR or Term SOFR plus 2.75%
Maturity
April 6, 2028
Event
amendment
Exact text from the filing
among other things (i) provides for a refinancing of the existing revolving credit facility through a replacement of the existing $250,000,000 revolving credit facility with a $300,000,000 revolving credit facility (the “Revolving Credit Facility”), which shall be on the same terms as the existing revolving credit facility (with the exception of the maturity date
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

AGILITI, INC. \DE amended Amendment No. 6 with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, and the lenders from time to time party thereto valued at $300,000,000 revolving credit facility (effective 2023-04-06).

Action
amendment
Agreement
credit facility
Counterparty
JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, and the lenders from time to time party thereto
Value
$300,000,000 revolving credit facility
Effective
2023-04-06
Exact text from the filing
On April 6, 2023, Agiliti Health, Inc., an indirect subsidiary of Agiliti, Inc. , entered into Amendment No. 6 (the “Amendment”) to the credit agreement, dated as of January 4, 2019 (as further amended, supplemented, amended and restated or otherwise modified from time to time, the “First Lien Credit Agreement”), by and among Agiliti Health, Inc., as borrower (the “Borrower”), Agiliti Holdco, Inc., as holdings, the subsidiaries of the Borrower from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, and the lenders from time to time party thereto.
View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR
accession 0001749704-23-000021
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.